General Information
Version
1.0
Revision date
2023-05-25
Product name
Holdup 750
REACH No
04743
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Barclay Chemicals Manufacturing Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@barclay.ie
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H290, H302, H302+H312, H312, H412
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May be corrosive to metals. Harmful in contact with skin. Harmful if swallowed. Harmful to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07
Signal word
Warning
Hazard statements
H290 - May be corrosive to metals. H302+H312 - Harmful if swallowed or in contact with skin. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. P302+P352 - IF ON SKIN: Wash with plenty of water. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P280 - Wear protective clothing, eye protection, face protection.
Supplemental label elements
EUH210 - Safety data sheet available on request. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %